Enzyme News and Research

RSS
Novel therapeutic agent could be effective for treating cancers with certain gene mutations

Novel therapeutic agent could be effective for treating cancers with certain gene mutations

Study brings scientists one step closer to solving the mystery of aging

Study brings scientists one step closer to solving the mystery of aging

Researchers discover camelid-derived two nanobodies that target SARS-CoV-2

Researchers discover camelid-derived two nanobodies that target SARS-CoV-2

Synergistic multi-antibody cocktail protects against SARS-CoV-2 in animal model

Synergistic multi-antibody cocktail protects against SARS-CoV-2 in animal model

Innovative testing platform could enable more precise, personalized immunotherapy

Innovative testing platform could enable more precise, personalized immunotherapy

SARS-CoV-2 reprograms host chromatic network to induce immune dysfunction

SARS-CoV-2 reprograms host chromatic network to induce immune dysfunction

Can prior human seasonal coronavirus antibody response patterns predict SARS-CoV-2 inhibition?

Can prior human seasonal coronavirus antibody response patterns predict SARS-CoV-2 inhibition?

Emerging SARS-CoV-2 mutations L452R & Y453F evade cellular immunity

Emerging SARS-CoV-2 mutations L452R & Y453F evade cellular immunity

Scientist explore conserved RNA elements as potential targets for anti-SARS-CoV-2 drugs

Scientist explore conserved RNA elements as potential targets for anti-SARS-CoV-2 drugs

Researchers identify immune protein linked to rare neurodegenerative disease

Researchers identify immune protein linked to rare neurodegenerative disease

Existing drug may be effective in treating COVID-19

Existing drug may be effective in treating COVID-19

Intestinal organoids demonstrate variability in SARS-CoV-2 susceptibility

Intestinal organoids demonstrate variability in SARS-CoV-2 susceptibility

Potent nasal vaccine protects non-human primates from SARS-CoV-2

Potent nasal vaccine protects non-human primates from SARS-CoV-2

Structural changes in receptor-binding interface may induce immune fitness of SARS-CoV-2 delta variant

Structural changes in receptor-binding interface may induce immune fitness of SARS-CoV-2 delta variant

Next-generation COVID-19 vaccine provides robust immunity against SARS-CoV-2 in mice

Next-generation COVID-19 vaccine provides robust immunity against SARS-CoV-2 in mice

Yeast expressed, RBD-based vaccine provides robust immune responses against SARS-CoV-2

Yeast expressed, RBD-based vaccine provides robust immune responses against SARS-CoV-2

Study proves effectiveness of Artemisia annua against SARS-CoV-2 in vitro

Study proves effectiveness of Artemisia annua against SARS-CoV-2 in vitro

Neutralizing antibodies persist against SARS-CoV-2 at least a year after infection

Neutralizing antibodies persist against SARS-CoV-2 at least a year after infection

A novel method developed for producing new antibiotics to combat resistant bacteria

A novel method developed for producing new antibiotics to combat resistant bacteria

Dysbiosis in gut microbiota may cause severe secondary infection in COVID-19 patients

Dysbiosis in gut microbiota may cause severe secondary infection in COVID-19 patients